Fluctuations of functionally distinct CD8+ T cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire
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Introduction
Increasing evidence suggests that pathogen-specific CD8+ T cells with diverse T cell receptor repertoires are beneficial for optimal suppression of rapidly evolving viruses such as hepatitis C 1 , LCMV 2 and HIV/SIV [3] [4] [5] [6] [7] . Virus-specific CD8+ T cells are an important effector arm of the immune defense against HIV-1/SIV infection [8] [9] [10] [11] [12] [13] [14] . After acute infection partial viral control is associated with persistent and often strong CD8+ T cell responses directed against several HIV epitopes 15, 16 . One such immunodominant epitope lies within HIV Nef ('FLKEKGGL' (residues 90-97)) and is restricted by HLA-B*0801 12, [17] [18] [19] [20] ("B8-FL8"). Epitope-specific responses are the sum of individually responding T cell clones with discrete T cell receptors and a structurally diverse TCR repertoire is likely to be necessary for optimal suppression of viremia in infections with the ability to rapidly evolve escape mutations 1, 3, [21] [22] [23] [24] . A diverse array of T cell receptors might decrease the chance of CTL-escape due to cross-recognition of mutated epitopes 25, 26 , and is also more likely to contain high affinity T cell clones able to efficiently recognize targeted epitopes and therefore mediate better control of virus replication 23 .
In HIV infection, perturbations of the peripheral T cell receptor repertoire have been described during primary infections [27] [28] [29] [30] and it has been hypothesized they are due to the clonal expansion and exhaustion of HIV-specific T cell clones during the initial viral burst of viremia after acute infection [31] [32] [33] . However, long-term persistence of HIV-1-specific CD8+ T cell clones has been observed in individuals with chronic or progressive HIV-1 infection 20, 34 . The possible effect of TCR diversity on disease outcome emphasizes the need to evaluate in more detail the dynamics of HIV epitope-specific T only.
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In this study, we longitudinally followed the TCR repertoire of HIV-1-specific CD8+ T cell responses in vivo in subjects with partial control of viremia. Most of the individuals were treated during acute infection and temporarily controlled plasma viremia after one or more supervised treatment interruptions (STI) 11, 35 . In these subjects, the T cell receptor repertoire of HIV-1-specific CD8+ T cells was oligoclonal with high structural diversity. Longitudinal analysis showed discordant expansions and contractions of distinct Vβ populations in response to changing levels of viremia. Functional analysis of distinct Vβ-populations revealed differences in antigen-specific IFN-γ secretion ex vivo.
Our study illustrates the functional diversity and kinetics of HIV-1-specific CD8+ T cells directed against an immunodominant HLA-class I restricted epitope. μM. The plates were incubated overnight at 37ºC, 5% CO2, and developed as described previously 37, 38 . Background was <20/10 6 PBMCs (2 spots/well at 100,000 PBMCs/well) PCR products of 500 to 600 base pairs were gel purified and cloned using the TOPO TA cloning kit (Invitrogen, Carlsbad, CA). Selected colonies were sequenced using the Taq DyeDeoxy Terminator cycle sequencing Kit (PE Applied Biosystems, Norwalk, CT) and capillary electrophoresis on an ABI 3700 PRISM automated sequencer (PE Applied Biosystems, Norwalk, CT).
Isolation of HIV-1-specific CTL Clones. CTL clones were isolated as previously described 3 and maintained in R10 with 100 U/ml rlL-2. Clones were stimulated with irradiated feeder cells and 1 μg/ml of the monoclonal antibody anti-CD3 antibody 12F6
(a generous gift from Johnson Wong/Massachusetts General Hospital). Clones were screened for HIV peptide-specific activity against autologous and/or HLA-class I matched B-LCL pulsed with the respective peptides.
Sequencing of autologous virus. Autologous virus was sequenced from plasma RNA using population sequencing, as described 41 . Viral RNA was isolated from plasma and nested PCR conducted using a set of described primers specific for HIV-1 41 
Results

B8-FL8 is a frequently targeted immunodominant HIV epitope in HIV-1 infected
HLA-B*08+ individuals
This study population was comprised of subjects expressing the HLA-B*08 allele, of which seven were diagnosed during acute or early HIV-1 infection 11, 12 . 
Structural diversity of immunodominant HIV-specific CD8+ T cells
We next evaluated the TCR diversity of CTL recognizing the B8-FL8 epitope by staining with a panel of Vβ-specific antibodies 4 and by sequencing the TCRβ chains of purified For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From of virema while interrupting antiretroviral treatment (data not shown) and was maintained on HAART with optimal viral suppression for over two years before entering our study.
We isolated HIV-specific CD8+ T cells based on their B8-FL8-tetramer binding (95-99% purity after enrichment; data not shown) and sequenced the TCRβ clonotypes as previously described 1, 4, 6, 40 . In subjects AC-14 and AC-15 six and seven different clonotypes respectively could be detected within the B8-FL8-specific CD8+ TCR repertoire. The majority of CDR3 amino acid sequences were heterogenous and there was no common motif detectable throughout the sequences. This was in sharp contrast to AC-42 in whom the TCR repertoire was dominated by a single clonotype representing the vast majority of the sequences (Figure 3a ).
In two subjects we were also able to isolate CTL clones specific for this epitope. We independently isolated B8-FL8 specific CD8+ T cell clones at two different time points from subject AC-42 (Supplemental Figure 1) . Peptide-specific IFN-γ secretion and cytotoxicity to peptide pulsed autologous target cells confirmed the specificity for B8- For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From specific cellular cytotoxicity utilized either the Vβ2 or Vβ14 variable region (data not shown). While TCR sequencing data provides more information regarding the diversity of the TCR repertoire, these results were concordant with the TCR variable region usage as assessed by antibody staining. In summary, we observed a heterogeneous oligoclonal TCR repertoire in subjects controlling viremia characterized by structural diversity within the antigen recognition site and by the utilization of a variety of TCR variable regions.
Longitudinal analysis of HIV-1-specific CD8+ T cells
HIV-1-specific immune responses need to respond to high levels of viral replication and a high degree of genetic variability. To understand the relationship between viral dynamics and the HIV-1 specific immune response in more detail at the epitope level, we next analyzed the kinetics of B8-FL8-specific CD8+ T cells in HIV-1-infected individuals. It has been previously shown that the breath and magnitude of HIV-specific T cell responses may be substantially altered in response to changes in viral load that occur during STI 12,18,42 . We were able to follow the magnitude and breadth of a dominant CD8+ T cell response in subjects with varying levels of viremia. In three subjects who suppressed plasma viremia after treatment discontinuation, we followed the evolution of the B8-FL8 specific CD8+ T cells for over one year ( Figure 4A) . Two of the individuals (AC-14 & AC-15) maintained control of viremia below 10,000 HIV-1 RNA copies/ml plasma for over one year before entering the study. The third individual (AC-47), also off therapy for over one year, had a higher HIV-1 viral load ranging between 10,000 and 50,000 copies/ml. All three subjects had B8-FL8 tetramer+ populations within their CD8+ T cells ranging from 1% to over 5%. Changes in levels of HIV-1 plasma viremia were paralleled by synchronous changes in the magnitude of the tetramer+ population only.
For Figure 4A ). For AC-42, who was on HAART during the entire study period, we observed a strong B8-FL8-tetramer+ population that remained stable (ranging between 2.5% and 3.5% of CD8+ T cells) over the entire study period with over one year of follow up ( Figure 4B) . In a fifth individual (AC-46) the frequency of tetramer+ cells was stable while this subject was on HAART; however, we observed an increase in the frequency of B8-FL8 tetramer+ CD8+ T cells after initiation of STI, which was synchronous with the increase in the level of viremia ( Figure 4C ). These data give evidence for an adaptive process of HIV-1-specific CD8+ T cells directed against immunodominant epitopes in response to changes in viremia.
Discordant variations within the antigen specific Vβ repertoire in individuals with replicating virus
Although it has been shown that different T cell clones can vary in their responsiveness to a range of antigen concentrations, or to variations within the recognized epitopes, evidence that this might influence the dynamics of the HIV-1-specific TCR repertoire in vivo is still lacking. With the majority of B8-FL8-specific CD8+ T cells utilizing more than one Vβ region in most subjects, we analyzed the kinetics of different Vβ populations over time. In our longitudinal analysis, we observed expansions or contractions of distinct Vβ populations in association with the HIV-1-specific CD8+ T cell population ( Figure   4 ). Importantly, substantial changes were only observed within subsets of Vβ populations, whereas the majority of Vβ populations in each response remained stable. 
these dynamic changes could also be observed during antiretroviral treatment with optimal viral suppression, we followed the Vβ repertoire of a dominant B8-FL8 tetramer+ CD8+ T cell population in subject AC-42 for more than one year ( Figure 4B ). This B8-FL8 tetramer+ CD8+ T cell population was dominated by a single Vβ8+ subpopulation that remained stable over one year of follow up.
Subject AC-46 was followed during a period of antiretroviral treatment and subsequent treatment interruption ( Figure 4C ). During antiretroviral treatment we identified two codominant Vβ populations, namely Vβ2 and Vβ14, which remained stable during antiretroviral treatment. After treatment was stopped we subsequently (within two weeks) observed a rise of the Vβ2+ population alone, whereas the Vβ14+ population remained stable. This 5-fold increase took place before a rise in plasma viremia was detectable. As viremia increased, we observed overall expansion of B8-FL8 tetramer+ CD8+ T cells, together with expansions and contractions of distinct Vβ populations within the tetramer+ cells over time (Figure 4 ). These data provide evidence that while changes in the overall frequency of HIV-1-specific CD8+ T cells may parallel changes in levels of viremia, within the epitope-specific T cell populations there may be discordant expansions and contractions of distinct subpopulations of T cells that can be identified by their Vβ TCR expression.
Individual Vβ populations differ in their tetramer expression patterns and their antigen specific IFN-γ secretion ex vivo
The finding of different kinetics of distinct B8-FL8 specific Vβ populations in vivo in patients with detectable viremia prompted us to investigate the functional role of HIV only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From epitope specific Vβ populations in more detail. Analysis by flow cytometry revealed subpopulations of cells with differences in the level of tetramer staining. Further analysis of these epitope-specific cells revealed differences in Vβ-utilization between these cell populations with different staining characteristics ( Figure 5 ). In subject AC-46 we analyzed the tetramer expression pattern of Vβ2+ and the Vβ14+ CD8+ T cell populations. Here, we observed that almost the entire Vβ14+ population (representing 18% of the tetramer+ cells) was in the tetramer low population, whereas the less frequent Vβ2+ population (9.5% of all tetramer+ cells) was located in the tetramer intermediate/high population ( Figure 5A ). In subject AC15 who also utilized the Vβ14 gene, the Vβ 14+ population was localized within the B8-FL8 tetramer high population ( Figure 5B ). Substantial heterogeneity in tetramer binding was present in subject AC-14 as well ( Figure 5C ). The dominantly utilized Vβ7.1 population (33.45% of B8-FL8 tetramer+ cells on day 1530) was located in the tetramer high population, whereas Vβ21.1 was located in the tetramer low positive population. Two other Vβ populations at that timepoint (Vβ13.2+ and Vβ23+) were located in the tetramer intermediate population ( Figure 5C ). The observation of heterogenous tetramer staining prompted us to perform a more detailed functional analysis of tetramer+ cells. 
Sequencing of autologous virus in subjects at viral set point
To understand the evolution of viral sequence variation in subjects that recognize the B8-FL8 epitope, we analyzed the autologous virus sequence of the B8-FL8 epitope, including the flanking regions, in four study subjects (Figure 7 ). In two subjects (AC-14 and AC-47) fluctuating amino acid changes were observed. For the other two subjects (AC-15 and AC-46) we did not observe sequence variation within the B8-FL8 epitope, yet these latter two subjects had evidence of discordant expansions and contractions within their epitope-specific Vβ populations. Our findings indicate that in subjects at viral set-point, even if sequence variants are present, they do not necessarily remained fixed in the population of viral quasispecies, and even when stable can be associated with fluctuations in the epitope-specific T cell repertoire. However, cross-sectional analysis did not show a significant correlation between HIVepitope specific CD8+ T cells and level of viremia in our cohort, as has also been observed in other studies 14 .
In chronic viral infections with high rates of viral mutations such as HCV or HIV infection a diverse TCR repertoire utilized by virus-specific CD8+ T cell responses has been hypothesized to be beneficial for control of viremia due to cross-recognition of epitope-variations 1, 3, 25, 45 . The objectives of this study were to characterize the TCR repertoires of immunodominant epitope-specific CD8+ T cells and to evaluate the kinetics and function of structurally diverse epitope-specific T cell receptor repertoires.
We determined the structure of the epitope-specific TCR repertoire by sequencing ex vivo purified HIV-specific CD8+ T cells and by staining with a panel of monoclonal antibodies specific for 24 Vβ regions as previously described 1, 4, 6, 40 . A recent study reported preferential Vβ 13.2 gene usage by B8-FL8-specific CD8+ T cells in subjects maintaining CD4 counts >500 for longer than 8 years 46 . Although we observed an only.
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Furthermore, only 2 of our subjects had significant populations of tetramer+ cells expressing the Vβ 13.2 TCR, and in neither case was it the dominantly expressed TCR beta chain. Possible reasons for these apparently discordant results include the different populations studied. Our cohort of subjects was at an early stage of HIV infection, and was promptly started on antiretroviral therapy, which may have preserved a more diverse TCR repertoire. Dong et. al. 46 studied subjects with chronic infection and uncontrolled viremia, which may limit TCR diversity over the course of disease. In ongoing studies, we are evaluating subjects at later stages of infection, and with varying levels of control of viremia to determine the association between the breadth of the TCR repertoire and control of viremia.
Due to the limitations in the number of cells available in our study we were not able to perform a comparison of TCR-sequencing with the corresponding Vβ staining at the same study visit. However, a comprehensive analysis of the reproducibility of this method has been published earlier by our group 1, 4 . Moreover, Vβ-region usage analyzed by sequencing and staining with Vβ-specific antibodies at different visits only a few weeks apart was similar and all Vβ-populations detected by sequencing were detectable by Vβ-staining. Our findings are consistent with earlier observations from our group and others demonstrating a polyclonal or diverse TCR repertoire within epitope-specific only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From responses in HIV and SIV infection 4, 6, 29, 45, [47] [48] [49] . Interestingly, the subject in this study with the narrowest TCR usage was on HAART with an undetectable viral load.
To We also wished to determine whether distinct HIV epitope-specific CD8+ T cell subpopulations showed differences in response to peptide stimulation ex vivo.
Differences in tetramer expression in HIV-infected subject have been previously In summary, we provide evidence that the magnitude of an epitope-specific CD8+ T cell response is a reactive process driven by the extent of replicating virus and involves subpopulations of functionally distinct epitope-specific CD8+ T cells, which could be defined by their expressed T cell receptors. Our results provide evidence of rapid changes within the TCR-repertoire of HIV epitope-specific CD8+ T cells and suggest that the ability to maintain a diverse and, more importantly, a dynamic TCR repertoire directed against viral epitopes might be a crucial factor for control of viral replication. A at study entry. M= male, w= Caucasian, b= African American, n.d.= no data, off= without antiretroviral treatment during study, on= antiretroviral treatment during study, on/off= treatment interruption, STI= individual participating in the structural treatment interruption trial 11 .
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